Optical coherence tomography detection of retinal neural loss in patients with tuberous sclerosis

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
DIAS, Paula Basso
LINHARES, Anna Carolina Badotti
URZEDO, Ana Barbara Dias Lopes
HOKAZONO, Kenzo
Citação
INTERNATIONAL JOURNAL OF RETINA AND VITREOUS, v.10, n.1, article ID 15, 9p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
PurposeTuberous Sclerosis (TS) is a rare, multisystem genetic disease caused by mutations in the TSC1 and TSC2 genes, leading to abnormalities in cell differentiation and proliferation. This study aimed to evaluate the neural integrity of individuals with TS by using Optical Coherence Tomography (OCT) to examine the peripapillary retinal nerve fiber layer (RNFL) thickness and the macular thickness in patients with TS and to compare with healthy controls.MethodsPeripapillary and macular OCT scans (Optopol Revo NX SD OCT) were performed on 41 eyes from 22 TS patients, divided into two groups based on the presence of retinal hamartomas, and compared to 20 eyes from a control group. The average peripapillary RNFL thickness was measured for each quadrant. The macular total thickness and ganglion cell layer (GCL) + inner plexiform layer (IPL) thickness were measured based on the Early Treatment Diabetic Retinopathy Study (ETDRS) map. All measurements were then compared between the groups and controls.ResultsThe TS group showed significantly reduced RNFL thickness and macular thickness when compared to the control group. Specifically, patients with retinal hamartomas exhibited an even more pronounced thinning of both RNFL and macular thickness.ConclusionsThese findings suggest that TS patients undergo significant changes in retinal neurodevelopment and experience axonal loss. This finding may have significant prognostic utility regarding central nervous system degeneration in TS, particularly among patients with retinal hamartomas. OCT may serve as a valuable tool for assessing axonal structural abnormalities in TS patients.Trial Registration Number: Not applicable.ConclusionsThese findings suggest that TS patients undergo significant changes in retinal neurodevelopment and experience axonal loss. This finding may have significant prognostic utility regarding central nervous system degeneration in TS, particularly among patients with retinal hamartomas. OCT may serve as a valuable tool for assessing axonal structural abnormalities in TS patients.Trial Registration Number: Not applicable.
Palavras-chave
Tuberous sclerosis complex, Retinal nerve fiber layer thickness, Macular thickness, Optical coherence tomography (OCT)
Referências
  1. Andrade C, 2016, MOVEMENT DISORD, V31, P377, DOI 10.1002/mds.26486
  2. Aronow ME, 2012, OPHTHALMOLOGY, V119, P1917, DOI 10.1016/j.ophtha.2012.03.020
  3. Boer K, 2008, NEUROPATHOLOGY, V28, P577, DOI 10.1111/j.1440-1789.2008.00920.x
  4. Costa-Cunha LVF, 2009, AM J OPHTHALMOL, V147, P56, DOI 10.1016/j.ajo.2008.07.020
  5. Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323
  6. Cunha Leonardo Provetti, 2016, Int J Retina Vitreous, V2, P24
  7. Fernandes DB, 2013, OPHTHALMOLOGY, V120, P387, DOI 10.1016/j.ophtha.2012.07.066
  8. Garaci FG, 2004, RADIOLOGY, V232, P461, DOI 10.1148/radiol.2322030198
  9. Gialloreti LE, 2015, CHILD NERV SYST, V31, P857, DOI 10.1007/s00381-015-2702-x
  10. Hodgson N, 2017, CLIN EXP OPHTHALMOL, V45, P81, DOI 10.1111/ceo.12806
  11. Kato A, 2019, EUR J OPHTHALMOL, V29, P330, DOI 10.1177/1120672118787441
  12. Marcotte L, 2012, ACTA NEUROPATHOL, V123, P685, DOI 10.1007/s00401-012-0950-3
  13. Mello LGM, 2020, MOVEMENT DISORD, V35, P2357, DOI 10.1002/mds.28280
  14. Northrup H, 2013, PEDIATR NEUROL, V49, P243, DOI 10.1016/j.pediatrneurol.2013.08.001
  15. Peters JM, 2012, ACAD RADIOL, V19, P17, DOI 10.1016/j.acra.2011.08.016
  16. Pichi F, 2016, RETINA-J RET VIT DIS, V36, P1199, DOI 10.1097/IAE.0000000000000829
  17. Shields CL, 2006, OPHTHALMOLOGY, V113, P1553, DOI 10.1016/j.ophtha.2006.03.032
  18. Zhang CX, 2020, GRAEF ARCH CLIN EXP, V258, P887, DOI 10.1007/s00417-019-04476-y